DOI:
10.1055/s-00025476
Endoscopy International Open
LinksClose Window
References
Ramanathan RK, Goldstein D, Korn RL. et al.
Positron emission tomography response evaluation from a randomized phase III trial of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas.
Ann Oncol 2016;
27: 648-653
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.